Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
Mutsunori Murahashi(Jikei University School of Medicine), Kenzaburo Tani(Tokyo Medical University), Kazunari Yamada(Kyushu University Hospital), Sachiko Yoshimura(OncoTherapy Science (Japan)), Hisanobu Ogata(Kyushu University), Yasuki Hijikata(Kyushu University Hospital), Tetsuro Hikichi(OncoTherapy Science (Japan)), Yoichi Nakanishi(RIKEN Center for Integrative Medical Sciences), Toshihisa Tsuruta(Nagoya University Hospital), Junji Kishimoto(Kyushu University Hospital)
Cited by 13
Related Papers
Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads
|The Journal of Immunology|2008|183
Deletion of the SOCS3 Gene in Liver Parenchymal Cells Promotes Hepatitis–Induced Hepatocarcinogenesis
|Gastroenterology|2006|180
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
|Journal of Clinical Oncology|2016|160